Back to Results

A RANDOMIZED, OPEN-LABEL, ACTIVE CONTROLLED, SAFETY AND DESCRIPTIVE EFFICACY STUDY IN PEDIATRIC SUBJECTS REQUIRING ANTICOAGULATION FOR THE TREATMENT OF A VENOUS THROMBOEMBOLIC EVENT

Study category: Heart and Blood Conditions

Is this Study for You?

Let's Get Started!

Details
Age

Child

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Treatment

Location

Childrens Hospital Colorado

Principal Investigator
Taizo Nakano

Taizo Nakano

Study ID

Protocol Number: 15-1434

More information available at ClinicalTrials.gov: NCT02464969

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers